Approach to Vasculitis

Contents

    BOTTOM LINE

    Vasculitis is a heterogenous group of diseases classified by blood vessel size. Large vessel vasculitis symptoms include claudication, bruits, aneurysms, asymmetrical blood pressures/pulses. Medium vessel includes skin nodules/ulcers, livedo, bowel infarction, and digital necrosis. Small vessel includes petechiae/pupura, glomerulonephritis, alveolar hemorrhage, and mononeuritis multiplex. Each specific vasculitis; each blood vessel size presents with predictable signs and symptoms of vasculitis. Thus, a careful history and exam can tell us which blood vessel size is affected, which vasculitis diagnoses may be responsible, and what confirmatory tests to order. Treatment is generally commensurate with degree of organ dysfunction.
    [🕑 3 minute read | 🗎 PDF Handout]

    CLASSIFICATION

    2012 Revised International Chapel Hill Consensus (Click image Enlarge)
    VESSEL SIZEPossible Symptoms/Signs
    Large Vessel
    Aorta and major branches (ex: carotid, subclavian, iliac)
    Limb claudication, bruits, asymmetric blood pressures, pulse deficit, aortic aneurysm, cranial symptoms (temporal headache, jaw claudication, blindness)
    Medium Vessel
    Main visceral arteries/veins and initial branches (ex: renal, mesentery, deep skin, nerves)
    Skin nodules and ulcers, livedo reticularis, digital necrosis, mononeuritis multiplex, renovascular hypertension, bowel infarction
    Small Vessel
    Intraparenchymal vessels
    (ex: glomeruli, alveoli, superficial skin, nerves)
    Palpable purpura, GN, alveolar hemorrhage,
    scleritis, mononeuritis multiplex, urticaria >24h

    Each specific vasculitis affects a predictable size of blood vessel.

    Each blood vessel size presents with predictable signs and symptoms of vasculitis.

    Thus, a careful history and exam can tell us which blood vessel size is affected, which vasculitis diagnoses may be responsible, and what confirmatory tests to order.

    DEFINITIONS

    2012 Chapel Hill Consensus

    LARGE VESSEL VASCULITIS

    • Giant Cell Arteritis (GCA)
      • Arteritis, often granulomatous, of aorta and/major branches—especially cranial (ex: temporal), carotid, vertebral arteries. Patient >50 years (mean age ~70), PMR association.
    • Takayasu Arteritis (TAK)
      • Arteritis, often granulomatous, of aorta/major branches. Usually patients <50 years.

    MEDIUM VESSEL VASCULITIS

    • Polyarteritis nodosa (PAN)
      • Necrotizing arteritis of medium/small arteries without glomerulonephritis; ANCA negative.
    • Kawasaki disease (KD)
      • Arteritis of medium and small arteries with the mucocutaneous lymph node syndrome. Coronary arteries, aorta and large arteries may be involved. Paediatric disease.

    SMALL VESSEL VASCULITIS

    ANCA-associated Vasculitis (AAV)
    Necrotizing pauci-immune (few/no immune deposits) vasculitis of small vessels with ANCA association in many.

    • GPA (Granulomatosis with Polyangiitis)
      • Necrotizing pauci-immune small/medium-vessel vasculitis usually involving upper/lower respiratory tract. Necrotizing glomerulonephritis is common.
    • MPA (Microscopic Polyangiitis)
      • Necrotizing pauci-immune small-vessel vasculitis; medium arteries may be involved.
        Necrotizing glomerulonephritis and pulmonary capillaritis common. No granulomas
    • EGPA (Eosinophilic granulomatosis with polyangiitis)
      • Necrotizing pauci-immune small/medium-vessel vasculitis with eosinophil-rich inflammation. Associated with asthma and other eosinophilia.

    Immune-complex vasculitis
    Vasculitis deposition of immunoglobulin and/or complement components on vessel wall, usually affecting small vessels. Glomerulonephritis is common.

    • Anti-GBM (Anti-glomerular Basement Membrane)
      • Vasculitis of glomerular capillaries or pulmonary capillaries (or both). Anti-GBM antibodies. Often presents with pulmonary hemorrhage/glomerulonephritis syndrome.
    • CV (Cryoglobulinemic vasculitis)
      • Vasculitis of small vessels with deposition of cryoglobulin; associated with serum cryoglobulins. Often presents with skin, glomeruli, and peripheral nerves involvement.
    • IGAV (IgA vasculitis, Henoch-Schönlein)
      • Vasculitis of small vessels  with IgA1-dominant immune deposits. Often presents with skin, GI, joint symptoms; can get glomerulonephritis.
    • HUV, anti-C1q vasculitis (Hypocomplementemic urticarial vasculitis)
      • Vasculitis/urticaria syndrome affecting small vessels; associated and hypocomplementemia and anti-C1q antibodies. Often presents with glomerulonephritis, arthritis, COPD, and ocular inflammation.

    VARIABLE VESSEL VASCULITIS

    Vasculitis with no predominant type of vessel involved that can affect vessels of any size (small, medium, and large) and type (arteries, veins, and capillaries).

    • Behcet’s Disease
      • Vasculitis affecting arteries or veins characterized by recurrent oral/genital ulcers. Often accompanied with skin, eye, joint, GI, and/or CNS inflammatory lesions. Small-vessel vasculitis, thromboangiitis, thrombosis, arteritis, and arterial aneurysms may occur.
    • Cogan’s Syndrome
      • Vasculitis characterized by eye and ear inflammation: keratitis, uveitis, episcleritis, sensorineural hearing loss and vestibular dysfunction. Other manifestations include arteritis, aortitis,  aortic aneurysms, and aortic and mitral valvulitis.

    OTHER VASCULITIS

    • Single-Organ Vasculitis
      • Vasculitis of any size in a single organ (ex: isolated skin vasculitis, isolated renal vasculitis, primary CNS vasculitis).
    • Vasculitis associated with systemic disease
      • Vasculitis associated or secondary to a systemic disease (ex: rheumatoid vasculitis, lupus vasculitis, malignancy, IBD).
    • Vasculitis associated with probable etiology
      • Vasculitis associated with a probable specific etiology (ex: drug-induced, hepatitis B-associated vasculitis).

    VASCULITIS MIMICS

    Large vessels· Atherosclerosis
    · Fibromuscular dysplasia
    · Congenital coarctation of aorta, middle aortic syndrome
    · Genetic diseases (Marfan syndrome, Ehlers-Danlos, Loeys–Dietz syndrome)
    · Infectious, acute: mycotic aneurysms associated with sepsis or endocarditis
    · Infectious, chronic: Syphilis, TB, HIV, leprosy
    · Isolated aortitis
    · IgG4 disease
    · Erdheim-Chester’s disease
    Medium vessels· Atherosclerosis
    · Fibromuscular dysplasia
    · Genetic diseases (Marfan syndrome, Ehlers-Danlos)
    · Thromboembolic disease
    · Cholesterol emboli syndrome
    · Calciphylaxis
    · Segmental arterial mediolysis (SAM)
    Cerebral vessels· RCVS
    · PRES
    · Cerebral amyloid angiopathy
    · Moyamoya disease
    · CADASIL
    · ADA2 deficiency/DADA2, Sneddon syndrome
    · CNS  lymphoma
    Small vessels· Infectious endocarditis or other cardiogenic emboli, Atrial myxoma
    · Cholesterol microemboli syndrome
    · Thromboembolic disease
    · Anti-phospholipid antibody syndrome
    · Sepsis other infection
    · Cocaine
    · TTP
    · Calciphylaxis
    · Intravascular lymphoma

    REFERENCES

    Grayson, P. C., Ponte, C., Suppiah, R., Robson, J. C., Craven, A., Judge, A., Khalid, S., Hutchings, A., Luqmani, R. A., Watts, R. A., Merkel, P. A., & DCVAS Study Group (2022). 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Arthritis & rheumatology (Hoboken, N.J.), 74(3), 386–392. https://doi.org/10.1002/art.41982

    Grayson, P. C., Ponte, C., Suppiah, R., Robson, J. C., Gribbons, K. B., Judge, A., Craven, A., Khalid, S., Hutchings, A., Danda, D., Luqmani, R. A., Watts, R. A., Merkel, P. A., & DCVAS Study Group (2022). 2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis. Arthritis & rheumatology (Hoboken, N.J.), 74(12), 1872–1880. https://doi.org/10.1002/art.42324

    Ponte, C., Grayson, P. C., Robson, J. C., Suppiah, R., Gribbons, K. B., Judge, A., Craven, A., Khalid, S., Hutchings, A., Watts, R. A., Merkel, P. A., Luqmani, R. A., & DCVAS Study Group (2022). 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis. Arthritis & rheumatology (Hoboken, N.J.), 74(12), 1881–1889. https://doi.org/10.1002/art.42325

    Jennette J.C, Falk R.J, Bacon P.A, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides.  Arthritis Rheum . 2013;65:1–11.

    Maningding, E., & Kermani, T. A. (2021). Mimics of vasculitis. Rheumatology (Oxford, England), 60(1), 34–47. https://doi.org/10.1093/rheumatology/keaa495

    Miloslavsky E.M, Stone J.H, Unizony S.H. Challenging mimickers of primary systemic vasculitis.  Rheum Dis Clin North America . 2015;41:141–160.

    Molloy, E. S., & Langford, C. A. (2008). Vasculitis mimics. Current opinion in rheumatology, 20(1), 29–34. https://doi.org/10.1097/BOR.0b013e3282f1dcf2

    Ponte, C., Grayson, P. C., Robson, J. C., Suppiah, R., Gribbons, K. B., Judge, A., Craven, A., Khalid, S., Hutchings, A., Watts, R. A., Merkel, P. A., Luqmani, R. A., & DCVAS Study Group (2022). 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis. Arthritis & rheumatology (Hoboken, N.J.), 74(12), 1881–1889. https://doi.org/10.1002/art.42325

    Robson, J. C., Grayson, P. C., Ponte, C., Suppiah, R., Craven, A., Judge, A., Khalid, S., Hutchings, A., Watts, R. A., Merkel, P. A., Luqmani, R. A., & DCVAS Investigators (2022). 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Annals of the rheumatic diseases, 81(3), 315–320. https://doi.org/10.1136/annrheumdis-2021-221795

    Sunderkötter, C. H., Zelger, B., Chen, K. R., Requena, L., Piette, W., Carlson, J. A., Dutz, J., Lamprecht, P., Mahr, A., Aberer, E., Werth, V. P., Wetter, D. A., Kawana, S., Luqmani, R., Frances, C., Jorizzo, J., Watts, J. R., Metze, D., Caproni, M., Alpsoy, E., … Jennette, J. C. (2018). Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis & rheumatology (Hoboken, N.J.), 70(2), 171–184. https://doi.org/10.1002/art.40375

    Suppiah, R., Robson, J. C., Grayson, P. C., Ponte, C., Craven, A., Khalid, S., Judge, A., Hutchings, A., Merkel, P. A., Luqmani, R. A., Watts, R. A., & DCVAS INVESTIGATORS (2022). 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Annals of the rheumatic diseases, 81(3), 321–326. https://doi.org/10.1136/annrheumdis-2021-221796

    Zarka, F., Veillette, C., & Makhzoum, J. P. (2020). A Review of Primary Vasculitis Mimickers Based on the Chapel Hill Consensus Classification. International journal of rheumatology, 2020, 8392542. https://doi.org/10.1155/2020/8392542

    Updated on August 13, 2026